Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Bioequivalence Study of Two Orodispersible Rizatriptan Formulations of 10 mg in Healthy Volunteers.

Cánovas M, Polonio F, Cabré F.

Sci Pharm. 2016 Jun 13;84(3):514-522. doi: 10.3390/scipharm84030514.

2.

Transoral ultrasonic total laryngectomy (TOUSS-TL): description of a new endoscopic approach and report of two cases.

Fernández-Fernández MM, González LM, Calvo CR, Arias PP, Cabré FC, Del Álamo PO.

Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2689-96. doi: 10.1007/s00405-015-3784-5. Epub 2015 Oct 1.

3.

Bioequivalence studies for 2 different strengths of irbesartan/hydrochlorothiazide combination in healthy volunteers: 300/25 mg and 300/12.5 mg film-coated tablets.

Cánovas M, Cabré F, Polonio F.

Drug Res (Stuttg). 2014 May;64(5):257-62. doi: 10.1055/s-0033-1357179. Epub 2013 Oct 8.

PMID:
24105103
4.

Bioequivalence study of two oral formulations of irbesartan 300 mg in healthy volunteers.

Cánovas M, Cabré F, Polonio F.

Drug Res (Stuttg). 2014 Jan;64(1):53-6. doi: 10.1055/s-0033-1353172. Epub 2013 Sep 18.

PMID:
24048950
5.

Bioequivalence study of 2 orodispersible formulations of zolmitriptan 5 mg in healthy volunteers.

Cánovas M, Canals M, Polonio F, Cabré F.

Arzneimittelforschung. 2012 Oct;62(10):482-6. doi: 10.1055/s-0032-1321848. Epub 2012 Aug 23.

PMID:
22918855
6.

Bioequivalence study of 2 orodispersible formulations of ondansetron 8 mg in healthy volunteers.

Cánovas M, Rios J, Domenech G, Cebrecos J, Pelagio P, Canals M, Polonio F, Cabré F.

Arzneimittelforschung. 2012 Feb;62(2):59-62. doi: 10.1055/s-0031-1295488. Epub 2012 Feb 16.

PMID:
22344549
7.

Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers.

Cánovas M, Arcabell M, Martínez G, Canals M, Cabré F.

Arzneimittelforschung. 2011;61(11):610-6. doi: 10.1055/s-0031-1300563.

PMID:
22232849
8.

Bioequivalence evaluation of two oral formulations of quetiapine fumarate in healthy volunteers.

Cánovas M, Torres F, Domenech G, Cebrecos J, Pelagio P, Martínez G, Polonio F, Cabré F.

Arzneimittelforschung. 2011;61(9):489-93.

PMID:
22029223
9.

Bioequivalence evaluation of two dosage forms of olanzapine 10 mg formulations in healthy volunteers.

Cánovas M, Torres F, Domenech G, Cebrecos J, Pelagio P, Manríquez M, Martínez G, Arcabell M, Cabré F.

Arzneimittelforschung. 2011;61(2):75-9. doi: 10.1055/s-0031-1296170.

PMID:
21428240
10.

Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers.

Cánovas M, Delgadillo J, Torres F, Riba N, Cebrecos J, Pelagio P, Cabré F.

Int J Clin Pharmacol Ther. 2009 Feb;47(2):124-31.

PMID:
19203569
11.

Evidence for a central mechanism of action of S-(+)-ketoprofen.

Díaz-Reval MI, Ventura-Martínez R, Déciga-Campos M, Terrón JA, Cabré F, López-Muñoz FJ.

Eur J Pharmacol. 2004 Jan 12;483(2-3):241-8.

PMID:
14729113
12.

Pharmacological profile of MEN91507, a new CysLT(1) receptor antagonist.

Cabré F, Carabaza A, García AM, Calvo L, Cucchi P, Palomer A, Pascual J, García ML, Manzini S, Lecci A, Crea A, Maggi CA.

Eur J Pharmacol. 2002 Sep 20;451(3):317-26.

PMID:
12242094
13.

Mechanisms involved in the attenuation of intestinal toxicity induced by (S)-(+)-ketoprofen in re-fed rats.

Nieto AI, Cabré F, Moreno FJ, Alarcón de la Lastra C.

Dig Dis Sci. 2002 Apr;47(4):905-13.

PMID:
11991627
14.

Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression.

Alarcón de la Lastra C, Nieto A, Martín MJ, Cabré F, Herrerías JM, Motilva V.

Inflamm Res. 2002 Feb;51(2):51-7.

PMID:
11930903
15.

Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.

Palomer A, Cabré F, Pascual J, Campos J, Trujillo MA, Entrena A, Gallo MA, García L, Mauleón D, Espinosa A.

J Med Chem. 2002 Mar 28;45(7):1402-11.

PMID:
11906281
16.

Structure-based design of cyclooxygenase-2 selectivity into ketoprofen.

Palomer A, Pascual J, Cabré M, Borràs L, González G, Aparici M, Carabaza A, Cabré F, García ML, Mauleón D.

Bioorg Med Chem Lett. 2002 Feb 25;12(4):533-7.

PMID:
11844666
17.

Estimation of acute flurbiprofen and ketoprofen toxicity in rat gastric mucosa at therapy-relevant doses.

Holzer P, Jocic M, Cabré F, Mauléon D.

Inflamm Res. 2001 Dec;50(12):602-8.

PMID:
11822786
18.

Analysis of antinociceptive effects of flurbiprofen enantiomers in a rat model of arthritic pain.

López-Muñoz FJ, Ventura R, Díaz MI, Hernández GP, Domínguez AM, García ML, Cabré F, Mauleón D.

Methods Find Exp Clin Pharmacol. 2000 Oct;22(8):641-5.

PMID:
11256237
19.

Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress.

de la Lastra CA, Nieto A, Motilva V, Martín MJ, Herrerías JM, Cabré F, Mauleón D.

Inflamm Res. 2000 Nov;49(11):627-32.

PMID:
11131303
20.

Synthesis and pharmacological evaluation of new 4-2-(7-heterocyclemethoxynaftalen-2-ylmethoxy)ethylbenzoic acids as LTD(4)-antagonists.

Ballart B, Martí J, Velasco D, López-Calahorra F, Pascual J, Luisa García M, Cabré F, Mauleón D.

Eur J Med Chem. 2000 Apr;35(4):439-47.

PMID:
10858604
21.

Derivation of pharmacophore and CoMFA models for leukotriene D(4) receptor antagonists of the quinolinyl(bridged)aryl series.

Palomer A, Pascual J, Cabré F, García ML, Mauleón D.

J Med Chem. 2000 Feb 10;43(3):392-400.

PMID:
10669566
22.

Intestinal ulcerogenic effect of S(+)-ketoprofen in the rat.

Cabré F, Fernández F, Zapatero MI, Araño A, García ML, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):27S-32S.

PMID:
9882079
23.

Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid.

López-Muñoz FJ, Ventura R, Díaz I, Fernández-Guasti A, Tost D, Cabré F, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):11S-21S.

PMID:
9882077
24.

Analgesic, antiinflammatory, and antipyretic effects of S(+)-ketoprofen in vivo.

Cabré F, Fernández MF, Calvo L, Ferrer X, García ML, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):3S-10S.

PMID:
9882076
25.

Antinociceptive Effects of S(+)-Ketoprofen and Other Analgesic Drugs in a Rat Model of Pain Induced Uric Acid.

López-Muñoz FJ, Ventura R, Díaz MI, Fernández-Guasti A, Tost D, Cabré F, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):11S-21S. doi: 10.1002/jcph.1998.38.s1.11.

PMID:
29023866
26.

Intestinal Ulcerogenic Effect of S(+)-Ketoprofen in the Rat.

Cabré F, Fernández MF, Zapatero MI, Arañó A, García ML, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):27S-32S. doi: 10.1002/jcph.1998.38.s1.27.

PMID:
29023865
27.

Analgesic, Antiinflammatory, and Antipyretic Effects of S(+)-Ketoprofen In Vivo.

Cabré F, Fernández MF, Calvo L, Ferrer X, García ML, Mauleón D.

J Clin Pharmacol. 1998 Dec;38(S1):3S-10S. doi: 10.1002/jcph.1998.38.s1.3.

PMID:
29023861
28.

Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases.

Iñiguez MA, Pablos JL, Carreira PE, Cabré F, Gomez-Reino JJ.

Br J Rheumatol. 1998 Jul;37(7):773-8.

PMID:
9714356
29.

Stereoselective inhibition of rat brain cyclooxygenase by dexketoprofen.

Carabaza A, Cabré F, García AM, Rotllan E, García ML, Mauleón D.

Chirality. 1997;9(3):281-5.

PMID:
9176993
30.

Differential effect of alkyl chain-modified ether lipids on protein kinase C autophosphorylation and histone phosphorylation.

Gil C, Molina E, Plana M, Carabaza A, Cabré F, Mauleón D, Carganico G, Itarte E.

Biochem Pharmacol. 1996 Dec 24;52(12):1843-7.

PMID:
8951342
31.

Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs.

Carabaza A, Cabré F, Rotllan E, Gómez M, Gutiérrez M, García ML, Mauleón D.

J Clin Pharmacol. 1996 Jun;36(6):505-12.

PMID:
8809635
32.

Effect of manoalide on human 5-lipoxygenase activity.

Cabré F, Carabaza A, Suesa N, García AM, Rotllan E, Gómez M, Tost D, Mauleón D, Carganico G.

Inflamm Res. 1996 May;45(5):218-23.

PMID:
8737743
33.

Stereoselective metabolic pathways of ketoprofen in the rat: incorporation into triacylglycerols and enantiomeric inversion.

Carabaza A, Suesa N, Tost D, Pascual J, Gomez M, Gutierrez M, Ortega E, Montserrat X, Garcia AM, Mis R, Cabre F, Mauleon D, Carganico G.

Chirality. 1996;8(2):163-72.

PMID:
8857179
34.

Rational modification of human synovial fluid phospholipase A2 inhibitors.

Pisabarro MT, Ortiz AR, Palomer A, Cabré F, García L, Wade RC, Gago F, Mauleón D, Carganico G.

J Med Chem. 1994 Feb 4;37(3):337-41. No abstract available.

PMID:
8308860
35.

Synthesis and release of platelet-activating factor and eicosanoids in human endothelial cells induced by different agonists.

Cabré F, Tost D, Suesa N, Gutiérrez M, Ucedo P, Mauleón D, Carganico G.

Agents Actions. 1993 Mar;38(3-4):212-9.

PMID:
8213348
36.

Inhibition of phospholipase A2 purified from human herniated disc.

Carabaza A, Cabré F, García AM, Gómez M, Sánchez J, Mauleón D, Carganico G.

Biochem Pharmacol. 1993 Feb 9;45(3):783-6.

PMID:
8442777
37.
38.

Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.

Cabré F, Moreno JJ, Carabaza A, Ortega E, Mauleón D, Carganico G.

Biochem Pharmacol. 1992 Aug 4;44(3):519-25.

PMID:
1387313
39.

Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2.

Cabré F, García AM, Carabaza A, Mauleón D, Carganico G.

Biochim Biophys Acta. 1992 Mar 25;1124(3):297-9.

PMID:
1576169
40.

An improved purification procedure for sulfite oxidase from bovine liver.

Cabré F, Cascante M, Canela EI.

Prep Biochem. 1991;21(1):53-61.

PMID:
1857684
41.

Occurrence and comparison of sulfite oxidase activity in mammalian tissues.

Cabré F, Marín C, Cascante M, Canela EI.

Biochem Med Metab Biol. 1990 Apr;43(2):159-62.

PMID:
2346671
42.
43.

Purification of adenosine deaminase from chicken-egg yolk by affinity column chromatography.

Lopez R, Cabre F, Franco R, Cascante M, Canela EI.

Prep Biochem. 1990;20(3-4):199-204.

PMID:
2287606
44.
45.

Identification and rejection of outliers in enzyme kinetics.

Lopez-Cabrera A, Cabré F, Franco R, Canela EI.

Int J Biomed Comput. 1988 Oct;23(1-2):9-20.

PMID:
3220600
46.

Unconventional nucleotide analogues. Synthesis of N-substituted 3-(adenin-9-yl)pyrrolidin-2-ones.

Doomen GJ, Kroon AP, Cabrè FR, Goores AP, Peereboom R, Pandit K.

J Chem Soc Perkin 1. 1973;17:1934-40. No abstract available.

PMID:
4363162

Supplemental Content

Support Center